SCHEMBL2928208

SCHEMBL2928208

O=Cc1ccc(OCc2ccccc2)c(CN2CCNCC2c2ccccc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.40
MAOA P21397 1/20 0.40
SLC6A4 P31645 3/20 0.38
HTR1A P08908 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A3 Q01959 1/20 0.38
ALDH1A1 P00352 3/20 0.38
HTR2C P28335 2/20 0.37
HTR2B P41595 1/20 0.37
HTR2A P28223 1/20 0.37
APP P05067 3/20 0.37
EGFR P00533 1/20 0.36
CALCA P06881 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
HTR6 P50406 1/20 0.35
LMNA P02545 1/20 0.35
THRB P10828 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2935828 0.79 ADAMTS5 (0.64)
SCHEMBL11708814 0.75 MAOB (0.51) MAOBALDH1A1EGFRSMN1; SMN2KDM4E
SCHEMBL1579802 0.73 SIGMAR1 (0.50) SLC6A4SLC6A2SLC6A3ALDH1A1CALCA
SCHEMBL2931945 0.72 MEN1 (0.53) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL978216 0.72 MAOA (0.60) MAOBMAOAHTR1AALDH1A1SMN1; SMN2
SCHEMBL2928206 0.72 DRD4 (0.48) MAOBMAOAALDH1A1LMNAKDM4E
SCHEMBL1897186 0.71 MAOA (0.59) MAOBMAOAHTR1AALDH1A1APP
SCHEMBL2932209 0.70 MAOA (0.57) MAOBMAOAALDH1A1LMNASMN1; SMN2
SCHEMBL5213883 0.69 MAOA (0.68) MAOBMAOAALDH1A1SMN1; SMN2KDM4E
SCHEMBL2933661 0.69 MAOA (0.56) MAOBMAOAHTR1AALDH1A1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313731-B1 THIAZOLIDINE DERIVATIVES AND ITS USE AS ANTIFUNGAL AGENT UCB SA (BE) 2010-09-29 EP disclosed
US-6740670-B2 SUCH AS 5-(((3-(N-METHYL-N-PHENYLAMINO)CARBONYL-4-(PHENYL-METHOXY)) -PHENYL)METHYLENE)-4-OXO-2-THIOXO-3-THIAZOLIDINE-ACETIC ACID OXFORD GLYCOSCIENCES (UK) LTD. (GB) 2004-05-25 US disclosed
US-20030216453-A1 Thiazolidine derivatives and its use as antifungal agent OXFORD GLYCOSCIENCES (UK) LTD (GB) 2003-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216453-A1 Thiazolidine derivatives and its use as antifungal agent CYP3A7, TAS2R7, OXSR1 MAOB 2540/4885MAOA 3397/4885SLC6A4 1269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.